Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Innovent Says GLP-1R/GCGR Dual Agonist Lowers Body Weight by 18.6%

publication date: Nov 2, 2023

Suzhou Innovent reported maxdutide, a GLP-1R/GCGR dual agonist, reduced body weight by 18.6% in obese patients after 48 weeks of treatment in a China Phase II trial. Innovent in-licensed Greater China rights to maxdutide from its long-term partner, Eli Lilly. Trial patients, who had moderate to severe obesity, received a high dose of 9mg. Besides the efficacy, maxdutide showed favorable safety and multiple metabolic benefits. Innovent plans to start a similar Phase III trial of the candidate before the end of the year. It is currently also conducting China trials at lower doses for obesity and type 2 diabetes. More details....

Stock Symbol: (HK: 01801)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here